Danaher Co. (NYSE:DHR) Holdings Trimmed by Private Advisor Group LLC

Private Advisor Group LLC trimmed its position in shares of Danaher Co. (NYSE:DHRGet Rating) by 35.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 75,288 shares of the conglomerate’s stock after selling 42,222 shares during the period. Private Advisor Group LLC’s holdings in Danaher were worth $24,770,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Maryland Capital Advisors Inc. purchased a new position in Danaher during the 4th quarter worth approximately $28,000. Dixon Hughes Goodman Wealth Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter valued at $29,000. Lee Financial Co acquired a new stake in shares of Danaher during the 4th quarter valued at $30,000. Evolution Advisers Inc. acquired a new stake in shares of Danaher during the 4th quarter valued at $32,000. Finally, Dark Forest Capital Management LP acquired a new stake in shares of Danaher during the 3rd quarter valued at $33,000. Hedge funds and other institutional investors own 78.42% of the company’s stock.

Shares of NYSE:DHR traded up $3.53 during trading on Tuesday, hitting $249.90. 13,812 shares of the stock were exchanged, compared to its average volume of 3,124,775. Danaher Co. has a 1-year low of $233.71 and a 1-year high of $333.96. The company has a market capitalization of $181.70 billion, a price-to-earnings ratio of 28.93, a price-to-earnings-growth ratio of 2.77 and a beta of 0.84. The company’s fifty day simple moving average is $272.24 and its 200-day simple moving average is $288.86. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.27 and a current ratio of 1.68.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings data on Thursday, April 21st. The conglomerate reported $2.76 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.11. Danaher had a return on equity of 18.64% and a net margin of 21.32%. The company had revenue of $7.69 billion for the quarter, compared to analyst estimates of $7.53 billion. During the same quarter last year, the firm earned $2.52 EPS. Danaher’s revenue for the quarter was up 11.6% compared to the same quarter last year. On average, research analysts forecast that Danaher Co. will post 10.31 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Friday, June 24th will be given a dividend of $0.25 per share. The ex-dividend date is Thursday, June 23rd. This represents a $1.00 annualized dividend and a dividend yield of 0.40%. Danaher’s dividend payout ratio (DPR) is presently 11.57%.

A number of brokerages recently weighed in on DHR. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating and set a $278.00 price objective on the stock. in a research note on Monday, April 25th. Royal Bank of Canada lowered their target price on Danaher from $311.00 to $299.00 and set a “sector perform” rating on the stock in a report on Friday, April 22nd. Robert W. Baird lowered their target price on Danaher from $334.00 to $319.00 and set an “outperform” rating on the stock in a report on Friday, April 22nd. UBS Group lowered their target price on Danaher from $365.00 to $340.00 in a report on Sunday, April 24th. Finally, Barclays lowered their target price on Danaher from $355.00 to $325.00 and set an “overweight” rating on the stock in a report on Thursday, January 27th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, Danaher presently has an average rating of “Buy” and an average target price of $331.14.

In related news, EVP Joakim Weidemanis sold 6,500 shares of the firm’s stock in a transaction that occurred on Monday, April 25th. The stock was sold at an average price of $255.74, for a total transaction of $1,662,310.00. Following the completion of the transaction, the executive vice president now owns 86,398 shares in the company, valued at approximately $22,095,424.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is owned by company insiders.

About Danaher (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.